T6	Exp 92 115	The molecular mechanism
T7	Exp 272 274	we
T8	Exp 345 359	the NF-AT site
T9	Exp 376 392	the octamer site
T10	Exp 464 478	its expression
T11	Exp 479 483	when
T12	Exp 409 423	This construct
T13	Exp 777 781	that
T14	Exp 825 829	that
T15	Exp 609 617	the -176
T16	Exp 637 663	the 4X NF-AT-Oct construct
T17	Exp 679 690	the ability
T18	Exp 733 741	the -236
T19	Exp 840 852	the presence
T20	Exp 856 882	the -150 AP-1 binding site
T21	Exp 921 931	the effect
T22	Exp 990 994	that
T23	Exp 1011 1015	both
T24	Exp 955 963	the -236
T25	Exp 995 1007	the presence
T26	Exp 1016 1039	the -130 AP-1-like site
T27	Exp 1059 1086	the -150 proximal AP-1 site
T28	Exp 1181 1183	it
T29	Exp 1254 1258	that
T30	Exp 1129 1142	the -180 site
T31	Exp 1223 1253	the normal mouse IL-2 enhancer
T32	Exp 1259 1268	this site
T33	Exp 1362 1366	that
T34	Exp 1433 1437	that
T35	Exp 1315 1333	The simplest model
T36	Exp 1496 1516	the trans-activation
T37	Exp 1520 1533	the IL-2 gene
T38	Exp 1345 1358	these results
R4	Coref Anaphora:T10 Antecedent:T2
R5	Coref Anaphora:T29 Antecedent:T31
R6	Coref Anaphora:T34 Antecedent:T39
T1	Protein 48 52	IL-2
T2	Protein 127 131	IL-2
T3	Protein 541 545	IL-2
T4	Protein 1240 1244	IL-2
T5	Protein 1524 1528	IL-2
T39	Exp 1402 1432	multiple transcription factors
